Gelteq (GELS) Cash from Operations Growth (1y) (2024 - 2025)
Gelteq (GELS) Cash from Operations Growth (1y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.45 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 425.00% |
| 10 | Gelteq | 674.80 | -47,886.84 | - | 69.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.76% |
| Dec 31, 2024 | -741.40% |